Barclays »

Maia Biotechnology shares owned by Barclays

Quarter-by-quarter ownership of Maia Biotechnology (MAIA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Maia Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Maia Biotechnology held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maia Biotechnology by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.0k 4.2k 1.44

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Maia Biotechnology

Solas Capital Management
Alyeska Investment Group
Vanguard Capital Management
683 Capital Management
Centric Wealth Management
Cable Car Capital
Geode Capital Management
Bleichroeder
Renaissance Technologies
Vanguard Fiduciary Trust
Bleakley Financial Group
State Street Corporation
BlackRock
Northern Trust
Bridgeway Capital Management

View all funds holding Maia Biotechnology